Department of Psychiatry and Behavioral Neuroscience, The University of Chicago Medicine, Chicago, IL.
Department of Psychology, College of Health Professions, Rosalind Franklin University, North Chicago, IL.
J Acquir Immune Defic Syndr. 2024 Jul 1;96(3):231-240. doi: 10.1097/QAI.0000000000003423.
People living with mental illness (PLMI) experience disproportionately high incidence of and vulnerability to HIV. Pre-exposure prophylaxis (PrEP) is an effective and safe HIV prevention method, but data regarding prescription to PLMI are lacking. Psychiatrists may serve as important points of access for PrEP prescription for PLMI.
We conducted a vignette-based study of residents in psychiatry and family medicine (FM) to assess likelihood of prescribing PrEP and assumptions about the fictional patient. Participants were randomized to one of five vignettes in which the patients' psychiatric diagnosis was varied (schizophrenia on long-acting injectable or oral antipsychotic, bipolar disorder, major depression) or a control vignette without a psychiatric diagnosis.
A total of 439 residents participated. We found that high percentages of psychiatry (96.8%) and FM (97.4%) residents were aware of PrEP. High percentages of psychiatry (92.0%-98.1%) and FM (80.8%-100%) residents reported that PrEP was indicated for all patient conditions. Family medicine residents were more likely to prescribe PrEP to all experimental conditions than psychiatry residents. There was no difference in likelihood of prescribing to the control condition without a psychiatric diagnosis. The belief that PrEP prescription was out of scope of practice was greater among psychiatry residents.
A majority of psychiatry residents responded that PrEP was indicated for an array of patients with psychiatric diagnoses. However, psychiatry residents were broadly less likely to prescribe PrEP to patients with these diagnoses. The high percentage of psychiatry residents who reported that PrEP was indicated for all patients suggests that additional training is needed to facilitate PrEP prescription by psychiatrists.
患有精神疾病的人(PLMI)经历 HIV 感染和易感性的比例过高。暴露前预防(PrEP)是一种有效且安全的 HIV 预防方法,但缺乏针对 PLMI 的处方数据。精神科医生可能是 PLMI 接受 PrEP 处方的重要切入点。
我们对精神科和家庭医学(FM)的住院医师进行了基于情景的研究,以评估他们为 PLMI 开 PrEP 处方的可能性以及对虚构患者的假设。参与者被随机分配到五个情景中的一个,患者的精神诊断不同(长效注射或口服抗精神病药的精神分裂症、双相情感障碍、重度抑郁症)或无精神诊断的对照情景。
共有 439 名住院医师参与。我们发现,精神科(96.8%)和 FM(97.4%)住院医师中,有很高比例的人了解 PrEP。精神科(92.0%-98.1%)和 FM(80.8%-100%)住院医师的高比例报告称,所有患者的情况都表明需要 PrEP。与精神科住院医师相比,家庭医学住院医师更有可能为所有实验条件开 PrEP 处方。认为 PrEP 处方超出实践范围的可能性在精神科住院医师中更大。
大多数精神科住院医师认为 PrEP 适用于一系列患有精神诊断的患者。然而,精神科住院医师普遍不太愿意为这些诊断的患者开 PrEP 处方。很大比例的精神科住院医师报告称,所有患者都需要 PrEP,这表明需要进行额外的培训,以促进精神科医生开 PrEP 处方。